What is Aurinia Pharmaceuticals's AOCI?

Aurinia Pharmaceuticals (AUPH) reported AOCI of -$880K in Q1 2026.

How has Aurinia Pharmaceuticals's AOCI changed year-over-year?

Aurinia Pharmaceuticals's AOCI decreased by 6.7% year-over-year, from -$825K to -$880K.

What is the long-term trend for Aurinia Pharmaceuticals's AOCI?

Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's AOCI has grown at a -5.7% compound annual growth rate (CAGR), from -$805K to -$599K.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

Aurinia Pharmaceuticals AUPH AOCI

AOCI at other companies

Rogers CorporationROG

-$55M+29.1%

Vera TherapeuticsVERA

-$156K-124%

AnaptysBio, Inc.ANAB

-$146K-191%

Ultragenyx PharmaceuticalRARE

$0+100%

Agios PharmaceuticalsAGIO

-$314K-186%

BridgeBio PharmaBBIO

-$8K—

Other financials

Income statement

See full

Revenue$77.7M+24.4%

Gross profit$71.2M+32.1%

Operating income$41.4M+89.6%

Net income$34.4M+47.2%

EPS (diluted)$0.25+56.3%

Balance sheet

See full

Cash & equivalents$41.0M-38.3%

Total debt$85.2M-7.9%

Total equity$567.6M+62.1%

Total assets$724.0M+43.4%

Cash flow

See full

Operating cash flow$32.6M+2,405%

Valuation

See full

Market cap$2.3B+78.5%

Enterprise value$2.34B+78.3%

P/E7.7×-24.6×

P/S7.7×+2.5×

Profitability

See full

Gross margin89.7%+1.5pp

Operating margin41.7%+29.4pp

Net margin100%+83.9pp

Returns & leverage

See full

Return on equity65%+53.8pp

Debt / equity0.2×-0.1×

Current ratio5.5×-0.4×

Where this comes from

Reported directly by Aurinia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aurinia Pharmaceuticals's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Aurinia Pharmaceuticals's AOCI?: Aurinia Pharmaceuticals (AUPH) reported AOCI of -$880K in Q1 2026.
How has Aurinia Pharmaceuticals's AOCI changed year-over-year?: Aurinia Pharmaceuticals's AOCI decreased by 6.7% year-over-year, from -$825K to -$880K.
What is the long-term trend for Aurinia Pharmaceuticals's AOCI?: Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's AOCI has grown at a -5.7% compound annual growth rate (CAGR), from -$805K to -$599K.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.